dose reduction of these concomitant agents is often necessary Thyroid C-cell tumors : Based on rodent studies, GLP-1 receptor agonists carry a boxed warning regarding medullary thyroid carcinoma risk and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Intestinal obstruction/ileus : Rare cases have been reported with some agents
It may support faster recovery when it comes to injuries and hard workouts, but it may also support those with chronic inflammatory conditions
In parallel with these resistance trends, the global population of immunocompromised individuals, including patients with malignancies, transplant recipients, individuals with HIV infection, and those receiving immunosuppressive therapies, is steadily increasing, further amplifying the clinical burden and therapeutic complexity of resistant candidiasis (Sahu et al., 2026a
Our post-hoc analyses revealed no significant effects of psychotropic medication use or the presence of comorbid ADHD or depression on Gln levels in these regions (Supplementary Methods S2, S3 and Supplementary Results S2, S3)
Many notice less soreness and better morning readiness
Prescription GLP-1 medications directly activate receptors that control appetite and blood sugar